Sientra appoints Philippe A. Schaison to board
Dr. Schaison has extensive experience leading global aesthetic organizations.
In November, 2016, Dr. Schaison joined Syneron Medical and currently serves as CEO of Syneron Candela North America and Global Executive Vice President Strategy and Business Development.
Previously, Dr. Schaison served as President of Allergan’s U.S. aesthetic and dermatology business.
Prior to joining Allergan, Dr. Schaison served as President, World Wide Travel Retail & Regional President, LATAM and MEA, at Clarins in New York.
Earlier, he served as CEO for Aesthetic Factors and as Vice President of Global Skin Care for Johnson & Johnson, with P&L responsibility for Aveeno, Clean & Clear, Lubriderm, and Ambi, and in executive positions at L'Oréal.
Dr. Schaison sits on the Board of the Galien Foundation and SENTÉ, Inc., a privately held specialty aesthetics company.
Dr. Schaison earned his MBA (Marketing) from the Hautes Etudes Commerciales (H.E.C.) in Paris, and a Doctorate in Pharmacy (Industrial) from the University of Paris. ■
LATEST MOVES FROM United Kingdom
- Charles Stanley Group appoints Marcia Campbell as director
- Arix Bioscience appoints Giles Kerr to board
- Crimson Tide appoints Tobias James Turness Hawkins to board
- Silence Therapeutics appoints Annalisa Jenkins to board
- Augean appoints two directors
More inside POST
Things successful leaders did only once Leadership